Home › Cutaneous T-Cell Lymphoma
Pag-aaral pangklinika para sa Cutaneous T-Cell Lymphoma na nagre-recruit sa U.S.
29 pag-aaral para sa Cutaneous T-Cell Lymphoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY9 pag-aaral
- Baldwin Park, CA8 pag-aaral
- Boston, MA5 pag-aaral
- Houston, TX5 pag-aaral
- New Haven, CT4 pag-aaral
- Chicago, IL3 pag-aaral
- Ann Arbor, MI3 pag-aaral
- Scottsdale, AZ3 pag-aaral
- Durham, NC3 pag-aaral
- Tampa, FL3 pag-aaral
- Columbus, OH3 pag-aaral
- Rochester, MN3 pag-aaral
Ayos sa estado
- Arizona3 pag-aaral
- California8 pag-aaral
- Connecticut4 pag-aaral
- Florida3 pag-aaral
- Illinois3 pag-aaral
- Massachusetts5 pag-aaral
- Michigan3 pag-aaral
- Minnesota3 pag-aaral
- New York10 pag-aaral
- North Carolina3 pag-aaral
- Ohio4 pag-aaral
- Pennsylvania4 pag-aaral
- Texas5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07192471Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT01087333A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07195916A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06854653Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04930653Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT03011814A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT04045470A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT06698822Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06860880Registry of Older Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 65 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT01137825Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT05313243A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT03017820A Registry for People With T-cell Lymphoma
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update May 20, 2026 · NCT05978141Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT05956041Characterization of the Microbiome in Cutaneous T Cell Lymphoma
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update May 1, 2026 · NCT03932279Photopheresis in Early-stage Mycosis Fungoides
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT05680558Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT07356245Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT05996185Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 1, 2026 · NCT07047885Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 10, 2026 · NCT04848064A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 4, 2026 · NCT05296304Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 28, 2026 · NCT04670874Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 30, 2025 · NCT00177268Amping up With PemJAK
Nagre-recruitPhase 2
Edad 18 hanggang 95 · Lahat ng kasarian · Na-update Dis 16, 2025 · NCT07283822Tissue Repository: CTCL Collection Protocol
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2025 · NCT02840747Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.